RWD149 Real-World Comparison of Cardiovascular Benefits between Sodium-Glucose Cotransporter 2 (SGLT-2I) and Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Inhibitors in Patients with Type 2 Diabetes (T2D)
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2178
https://www.valueinhealthjournal.com/article/S1098-3015(23)02278-7/fulltext
Title :
RWD149 Real-World Comparison of Cardiovascular Benefits between Sodium-Glucose Cotransporter 2 (SGLT-2I) and Glucagon-like Peptide-1 Receptor Agonist (GLP-1RA) Inhibitors in Patients with Type 2 Diabetes (T2D)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02278-7&doi=10.1016/j.jval.2023.03.2178
First page :
Section Title :
Open access? :
No
Section Order :
11495